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Abstract
Background: Sexual differentiation often has significant effects on life span and aging phenotypes. For
example, males and females of several species have different life spans, and genetic and environmental
manipulations that affect life span often have different magnitude of effect in males versus females.
Moreover, the presence of a differentiated germ-line has been shown to affect life span in several species,
including Drosophila and C. elegans.
Methods: Experiments were conducted to determine how alterations in sexual differentiation gene
activity might affect the life span of Drosophila melanogaster. Drosophila females heterozygous for the
tudor[1] mutation produce normal offspring, while their homozygous sisters produce offspring that lack a
germ line. To identify additional sexual differentiation genes that might affect life span, the conditional
transgenic system Geneswitch was employed, whereby feeding adult flies or developing larvae the drug
RU486 causes the over-expression of selected UAS-transgenes.
Results: In this study germ-line ablation caused by the maternal tudor[1] mutation was examined in a long-
lived genetic background, and was found to increase life span in males but not in females, consistent with
previous reports. Fitting the data to a Gompertz-Makeham model indicated that the maternal tudor[1]
mutation increases the life span of male progeny by decreasing age-independent mortality. The Geneswitch
system was used to screen through several UAS-type and EP-type P element mutations in genes that
regulate sexual differentiation, to determine if additional sex-specific effects on life span would be obtained.
Conditional over-expression of transformer female isoform (traF) during development produced male
adults with inhibited sexual differentiation, however this caused no significant change in life span. Over-
expression of doublesex female isoform (dsxF) during development was lethal to males, and produced a
limited number of female escapers, whereas over-expression of dsxF specifically in adults greatly reduced
both male and female life span. Similarly, over-expression of fruitless male isoform A (fru-MA) during
development was lethal to both males and females, whereas over-expression of fru-MA in adults greatly
reduced both male and female life span.
Conclusion:  Manipulation of sexual differentiation gene expression specifically in the adult, after
morphological sexual differentiation is complete, was still able to affect life span. In addition, by
manipulating gene expression during development, it was possible to significantly alter morphological
sexual differentiation without a significant effect on adult life span. The data demonstrate that manipulation
of sexual differentiation pathway genes either during development or in adults can affect adult life span.
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Background
The disposable soma theory suggests that aging occurs
because there is a selection pressure to assign limited bio-
logical resources to short-term survival, growth, and
reproduction, rather than long-term survival [1,2]. Con-
sistent with this idea, several studies have suggested that
there may exist a trade-off between reproduction and life
span. For example, in humans, longer life span has been
correlated with a smaller number of offspring [3], but see
also [4,5]. In C. elegans, elimination of reproduction by
ablation of the germ line extended life span by up to
+60% [6]. This effect was attributed to increased activity of
the insulin/IGF1-like signaling (IIS) pathway target tran-
scription factor DAF-16 in the gastrointestinal tract,
caused by reduced hormonal signaling from the gonad to
the intestine [7].
A trade-off between life span and reproduction does not
appear to be obligatory, because it is possible in certain
instances to increase life span in C. elegans and Drosophila
without causing a decrease in reproduction [8,9]. One
possibility is that it is sexual differentiation, rather than
reproduction per se, that exerts a cost on life span [10].
In Drosophila males and females often respond differently
to genetic or environmental interventions that extend life
span. For example, reduced IIS, dietary restriction and vir-
ginity each caused greater increase in life span in females
than in males [11,12]. Similarly, over-expression of
mutant forms of p53 preferentially increased female life
span [13,14]. Possible mechanisms for sex-specific life
spans include asymmetric inheritance of sex chromo-
somes, genetic differences between the sexes, differences
in physiology and behavior, maternal effects, and sexual
selection, sexual conflict, or sex linkage [10,11,15].
In Drosophila, elimination of germ cells (GCs) by forced
expression of the differentiation gene bam in late develop-
ment or adulthood was found to increase median life
span by +14% to +78% in males, and by +23% to +100%
in females [16]. The elimination of Drosophila GCs was
found to modulate IIS, by increasing nuclear localization
of the Drosophila homolog of DAF-16 (called dFoxo), and
by increasing the expression of Drosophila insulin-like pep-
tides (dilps) [16]. The Drosophila maternal effect genes germ
cell-less and tudor are necessary for the formation of the
germ line in offspring [17]. Interestingly, in another recent
study, it was concluded that elimination of Drosophila GCs
using germ cell-less and tudor mutations might not extend
life span [18], and the reason for the difference in results
in these previous studies may be differences in the timing
of germ cell ablation relative to fly development. Here the
maternal tudor[1] mutation was tested in a particularly
long-lived genetic background, and was found to increase
the life span of male offspring, but to have neutral or neg-
ative effects on female life span.
In the Drosophila  soma, sexual differentiation is deter-
mined by the X chromosome to autosome (X:A) ratio and
the on/off status of the master regulatory gene Sex-lethal
(Sxl) (Figure 1A), however cell-cell interactions also play
a role [19]. Sexual differentiation in the Drosophila germ
line is determined by germ line-autonomous signals, as
well as the interactions between the germ line and the
soma [20-22]. Genes in the somatic sex determination
hierarchy play important roles but are not the primary reg-
ulators in germ line sexual differentiation. For example,
Sxl promotes oogenic development in female germ cells,
but not in male germ cells.
To test if additional alterations in sexual differentiation
might affect fly life span, the Geneswitch system was used
to screen through several UAS-type and EP-type P element
mutations in genes that regulate sexual differentiation.
This approach allows genes to be over-expressed either
during Drosophila larval development, or specifically in
the adult stages. The Drosophila sex determination hierar-
chy consists of pre-mRNA splicing factors encoded by the
genes Sex-lethal (Sxl), transformer (tra), and transformer-2
(tra-2)  [23] (Figure 1A). In females (sex chromosome
composition X/X), the ratio of X chromosomes to auto-
somes results in the production of SXL protein, which
directs the pre-mRNA splicing of tra transcripts. The TRA
and TRA-2 proteins together direct the splicing of pre-
mRNAs for the transcription factor genes doublesex (dsx)
and fruitless (fru), such that females produce the female
form of the doublesex protein (DSXF ), and no sex-specific
forms of Fruitless protein. In males (sex chromosome
composition X/Y), the SXL and TRA products are not pro-
duced, which results in production of the male form of
doublesex (DSXM ), and the male form of Fruitless protein
(FRUM ). The DSX and FRU transcription factors then
direct sex-specific differentiation of tissues and the poten-
tial for sex-specific behaviors. The data presented here
demonstrate that the Drosophila  sexual differentiation
pathway can act during development and in adults to
affect longevity.
Methods
Drosophila Strains
The UAS-transgene strains were generated by various lab-
oratories, and stocks were obtained from Michelle Arbeit-
man at USC: The strain y w; P{UAS-fruMA}[7];+ is
described in [24]. The strain w; P{UAS-fru-IR}/CyO;
P{UAS-fru-IR} is described in [25]. The strain w; P{UAS-
dsxM}/CyO, GFP; + is described in [26]. The strain w; +;
P{UAS-dsxF}/TM3, Sb was generated by Ken Burtis and is
described in [27]. The strain w; P{UAS-tra} [20J7]; + isBMC Geriatrics 2009, 9:56 http://www.biomedcentral.com/1471-2318/9/56
Page 3 of 13
(page number not for citation purposes)
Drosophila sex determination hierarchy and the tudor mutation Figure 1
Drosophila sex determination hierarchy and the tudor mutation. A) The Drosophila somatic sex determination hierar-
chy. The X to autosome ratio causes Sxl to be "off" in males (indicated in gray color) and to be "on" in females. In males, lack of 
SXL and TRA activity leads to expression of FRUM and DSXM . In females, TRA and TRA2 together direct splicing of down-
stream targets to produce DSXF , and fru P1 transcripts that are not translated in females. B) Crossing scheme to produce 
germ line-ablated flies using tudor[1]. For the experimental group, tudor homozygote females were crossed to wild type Ore-
gon-R males to generate progeny lacking a germ line. For the control group, tudor heterozygote females were crossed to Ore-
gon-R males to generate progeny containing a normal germ line. Both experimental and control groups have the same 
chromosomal composition. B) Test for Wolbachia. The Wolbachia 16S rDNA sequences were amplified by PCR from the indi-
cated Drosophila lines and controls, and the presence or absence of Wolbachia-specific PCR products was determined by gel 
electrophoresis and ethidium bromide staining.
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described in [28]. The strains w; +; P{dsx-XP} [d09625]
and w; P{tra2-XP} [d10032]; + are described in [29]. The
strain y[1] w [67c23] P{EPgy2}Sxl [EY06108]/FM6B was
obtained from Bloomington Drosophila stock center. The
tudor[1] mutant strain [30] was also obtained from
Bloomington Drosophila stock center. The genotypes of all
strains are presented in Table 1. For experiments involving
tudor[1], the experimental group consisted of the progeny
of  tudor[1] homozygous females crossed to Oregon R
wild-types males, while the control group consisted of the
offspring of tudor[1] heterozygotes crossed to Oregon R
males. This resulted in control and experimental groups
with the same chromosomal composition, however the
experimental group lacks a germ line due to the maternal
effect of homozygous tudor[1] (Figure 1B). The tissue-gen-
eral Geneswitch driver line Act-GS-255B contains multiple
copies of a construct in which the tissue-general actin5C
promoter drives expression of the Geneswitch protein,
and has previously been described and characterized
[13,31]. Act-GS-255B virgins were used in the crosses with
males of other lines, unless the UAS insertion of the sex
differentiation gene or the EP (XP) insertion was on the X
chromosome, in which case the cross direction was
reversed.
Fly Culture
Drosophila  culture and life span assays were performed
essentially as previously described [31]. Briefly, Drosophila
were cultured on a dextrose, agar, yeast, and cornmeal
media [32], and adults were maintained at twenty-five
flies per vial. Survival assays were performed at 25°C.
Every two days, flies were transferred to new vials, and the
number of deaths was recorded. The drug RU486 (Mife-
pristone, Sigma) was dissolved in ethanol (100%) to
make a stock solution at 3.2 mg/ml. For adult feeding, 50
ul of RU486 stock solution was added to each vial to pro-
duce a final concentration of ~160 ug/ml; 50 ul ethanol
was added to the control vials. For larval feeding, 0.5 ml
of 3.2 mg/ml RU486 stock solution was added to each
bottle, whereas 0.5 ml ethanol was added to controls.
Vials and bottles were covered with cheesecloth and
allowed to dry overnight to allow the ethanol to evapo-
rate.
Wolbachia Test
Total DNA was extracted from ten male and ten female
flies of each line using the ZR Genomic DNA Kit II (Zymo
Research). The Drosophila DNA was then used as template
for PCR amplification with Wolbachia-specific primers,
and the products were fractionated on an agarose gel and
stained with ethidium bromide [32,33].
Phenotype Characterization
UAS-tra males were crossed to Act-GS-255B virgins, and
the progeny were cultured on food with drug (+RU486) to
drive the over expression of tra during development, or
cultured on food with ethanol as the control. Male and
female external genitalia, abdomenal pigmentation pat-
terns, and male sex combs were photographed using a
Leica MZ FLIII fluorescence stereomicroscope. Or-R and w
[1118] males were also crossed to Act-GS-255B virgins,
and the progeny were cultured on food supplemented
with drug (+RU486) or with ethanol only, as the controls.
Statistical Analysis
Mean, standard deviation, median, percent change in
mean, percent change in median, and log rank p value
were calculated using R 2.6.2. Analysis of mortality rate
was performed using the WinModest  statistical package
[34]. The best fit model was determined by the "Model
Comparison" option and confirmed by other additional
options of WinModest software. In the Gompertz-Make-
ham model, the increase of mortality (μx ) with age (x) is
expressed as: μx = aebx +c, where the constant a is the initial
Table 1: Starting stocks.
St# Genotype Notes Abbreviation
1 w [1118]; Act-GS-255B;+ Tissue-general Geneswitch driver 255B
2 y w; P{UAS-fruMA}[7]; + UAS-fru male A isoform fruMA
3 w; P{UAS-fru-IR}/CyO; P{UAS-fru-IR}  UAS-fru RNAi fruIR
4 w; P{UAS-dsxM}/CyO, GFP; + UAS-dsx male isoform dsxM
5 w P{UAS-tra2-IR} [61A]; +; P{UAS-tra2-IR} [82A] UAS-tra2 RNAi tra2IR
6 w [1118]; +; + Injection strain control
7 Oregon R (+; +; +) wild type control
9 w; +; P{UAS-dsxF}/TM3, Sb UAS-dsx female isoform dsx
10 w; P{UAS-tra} [20J7]; + UAS-tra tra
11 y[1] w [67c23] P{EPgy2}Sxl [EY06108]/FM6B EP-sxl sxl
14 w; +; P{dsx-XP} [d09625] XP-dsx dsx
15 w; P{tra2-XP} [d10032]; + XP-tra2 tra2
16 +; tud[1] bw sp/SM1; + tudor[1] mutantBMC Geriatrics 2009, 9:56 http://www.biomedcentral.com/1471-2318/9/56
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mortality rate, b is the rate of exponential increase in mor-
tality, and c is the age-independent mortality. WinModest
assumes that the observation on the cohorts is continuous
and ages at death are exact. Fly deaths were recorded every
other day. Therefore, age was divided by two before being
input into WinModest. The output age was then multiplied
by two to compensate for the initial division. Without
dividing the age by two and then multiplying the output
by two, the trend-lines based on the parameters (a, b, c)
would be too low, and would not perfectly match the
mortality data points. The natural logarithm of mortality
(Ln (μx )) for each time point was calculated by the Win-
Modest statistical software, based on: Px = Nx + 1 /Nx , μx = -
Ln(Px ). Parameters (a, b, c) were also calculated by the
WinModest statistical package, based on a likelihood ratio
test. The full model (aebx + c) was plotted, and the Gom-
pertz-only component (μx ) was used to build the decom-
posed survival curves, from the reverse calculation of μx :
μx = aebx ,  . For the decomposed survival curves,
any value below 0.5% survival was considered to be the
final data point.
Results
Female flies heterozygous or homozygous for the tudor[1]
mutation were crossed to Oregon-R wild-type male flies to
produce control offspring and offspring lacking the germ
line, respectively (Figure 1B). In the first experiment the
life span of control and germ line-ablated flies was meas-
ured using cohorts of ~125 flies each. For the germ line-
ablated male flies the mean and median life span was
increased by +19.9% and +12.9%, respectively, relative to
controls, whereas in contrast female life span was signifi-
cantly decreased (Table 2). To determine if these results
were reproducible, the experiment was repeated with
cohorts sizes of ~240 flies. Male mean and median life
span was again found to be increased by +19.97% and
+12.2%, respectively, whereas female life span was not
altered. Plots of percent survival versus time indicated that
there was also significant early mortality in several of the
cohorts (Figure 2A, D, G, J). Consequently, the Winmodest
statistical package was used to control for early mortality
and to analyze the survival data in greater detail. The data
was fitted to a Gompertz-Makeham model where the con-
stant a is the initial mortality rate, b is the rate of exponen-
tial increase in mortality, and c is the age-independent
mortality (Figure 2B, E, H, K). The values of a, b and c were
calculated based on a likelihood ratio test (Table 3). Re-
plotting of the fitted data using only the Gompertz term
yields a decomposed survival curve consisting of only the
age-dependent mortality (Figure 2C, F, I, L). The data indi-
cate that the increase in mean life span of germ line-
ablated males relative to controls can be attributed to a
decrease in age-independent mortality (rate constant c),
while the initial mortality rate (rate constant a) and mor-
tality rate increase with time (rate constant b) were not sig-
nificantly affected (Table 3). While the initial experiment
indicated a decrease in the life span of germ line-ablated
females relative to controls, this result was not reproduced
in the larger cohorts, where there was no significant differ-
ence in any of the mortality rate parameters between germ
line-ablated females and controls.
Wolbachia are gram-positive bacteria that are transmitted
in Drosophila through maternal inheritance [35]. These
bacteria are capable of altering life span, and can poten-
tially result in a false positive for life span extension
[8,36]. Therefore, the presence of Wolbachia was assayed
by PCR using primers specific for the Wolbachia 16S RNA
genes, and the lines used in this experiment were found
not to be infected (Figure 1C).
To begin to ask if other alterations in sexual differentia-
tion could affect life span, the Geneswitch system was
used to cause over-expression or inhibition of several
genes involved in the sex-determination pathway. Expres-
sion of the Geneswitch transcription factor was driven
Pe x
x =
−m
Table 2: Statistical analysis of tudor life span assays.
Group N Meana  Median % Change in Mean %Change in Median Log Rank p Value
Exp 1
Mutant Males 125 68.45 ± 11.37 70 19.91 12.90 4.25E-05
Control Males 122 57.08 ± 20.28 62
Mutant Females 118 47.36 ± 24.50 56 -20.99 -23.29 5.33E-10
Control Females 124 59.94 ± 28.03 73
Exp 2
Mutant Males 238 87.41 ± 18.03 92 19.97 12.20 1.00E-10
Control Males 139 72.86 ± 25.01 82
Mutant Females 233 74.33 ± 22.01 80 -2.04 0.00 0.121
Control Females 175 75.87 ± 21.78 80
a Mean life span, days +/- SD.BMC Geriatrics 2009, 9:56 http://www.biomedcentral.com/1471-2318/9/56
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with the cytoplasmic actin Actin5C promoter, using trans-
genic line Act-GS-255B. Feeding animals the drug RU486/
Mifepristone either during larval development or as adults
causes activation of the Geneswitch transcription factor,
which then binds to UAS sites in target promoters and
activates expression of the gene of interest or the RNAi
construct. To control for any effects of the drug itself, the
Act-GS-255B line was crossed to Oregon R wild type strain
to generate progeny containing Act-GS-255B but no target
construct. In these control flies, the drug treatment gener-
ally had no effect on life span, with the exception of two
experiments where life span of adult females was reduced
by -2% to -5% (Figure 3A, B; Table 4). The Act-GS-255B
line was also crossed to the w [1118] injection strain to
generate another control. In these control flies, the drug
treatment had no effect on male life span, and had a slight
effect on female life span ranging from -5% to +5% (Table
4). However, because these changes in controls were small
in magnitude and were not always observed, we interpret
these changes as being within the background of the
assay. The drug treatment during development caused no
visible alterations in sexual differentiation of the flies
(data not shown).
Conditional over-expression of the pre-mRNA splicing
factor gene tra during development significantly inhibited
sexual differentiation in males, resulting in a lack of much
of the external genitalia and a reduction in the size of the
sex combs (Figure 4C, D, E, F), however these flies did not
exhibit a significant change in life span (Figure 3C; Table
4). In contrast, in females, over-expression of tra during
development did not detectably affect sexual differentia-
tion (Figure 4A, B), and did not alter life span (Figure 3D;
Table 4). Over-expression of tra in adults gave no signifi-
cant change in male and female life span (Figure 3C, D;
Table 4). Repeats of the life span assay with tra  over-
expression produced similar results (Table 4, Exp3).
Conditional expression of the tra2 RNAi construct in
female adults resulted in a small but significant decrease
in life span of -12% (Figure 3F). However, expression of
the tra2 RNAi construct during male and female develop-
ment or in male adults did not affect life span (Figure 3E,
F; Table 4), nor did it have a detectable effect on morpho-
logical differentiation.
Over-expression of dsxM during development was toxic to
males and females and produced only a limited number
of adult escapers, while over-expression of dsxM in adults
caused a small but statistically significant reduction in
male and female life span, -5.5% and -7.8%, respectively
(Figure 3G, H and Table 4 Exp1); however, this apparent
reduction in life span upon over-expression of dsxM in
adults may not be significant, as it was similar in magni-
tude to the small variation in life span observed in con-
trols.
Over-expression of dsxF during development was lethal to
males and produced a limited number of females. This
observation is consistent with previous studies where
over-expression of DSX during development using a heat
shock promoter was found to cause lethality in both
males and females [37]. Interestingly, over-expression of
dsxF specifically in adults dramatically reduced male and
female mean life span, by -61.3% and -45.8%, respec-
tively (Figure 3I, J; Table 4, Exp1); and these results were
confirmed by repeated experiments (Table 4, Exp3). Sim-
ilarly, over-expression of the fru male isoform A (fru MA)
Table 3: Parameters for Gompertz-Makeham model and likelihood ratio test results.
Parameters Mutant Control chi2  df p Value chi2  df p Value
Tudor Exp 1 one parameter compared at each time
Males Both a and b are constrained
a1 . 0 0  ×  1 0 -4  7.00 × 10-5  0.13 1 0.724
b2 . 0 7  ×  1 0 -1  2.29 × 10-1  0.73 1 0.392
c2 . 0 6  ×  1 0 -9  7.52 × 10-3  17.65 1 < 0.001 23.76 1 < 0.001
Females c is constrained
a3 . 2 0  ×  1 0 -4  1.04 × 10-6  13.23 1 < 0.001 13.34 1 < 0.001
b1 . 9 3  ×  1 0 -1  2.91 × 10-1  5.84 1 0.016 5.47 1 0.019
c1 . 4 3  ×  1 0 -2  1.66 × 10-2  0.37 1 0.541
Tudor Exp 2
Males Both a and b are constrained
a8 . 3 8  ×  1 0 -8  6.03 × 10-7  2.60 1 0.107
b3 . 1 9  ×  1 0 -1  3.06 × 10-1  0.23 1 0.633
c1 . 6 7  ×  1 0 -3  4.67 × 10-3  7.98 1 0.005 18.46 1 < 0.001
Females
a6 . 4 0  ×  1 0 -7  3.46 × 10-7  0.33 1 0.565
b3 . 0 7  ×  1 0 -1  3.17 × 10-1  0.15 1 0.694
c3 . 7 6  ×  1 0 -3  3.69 × 10-3  0.00 1 0.949BMC Geriatrics 2009, 9:56 http://www.biomedcentral.com/1471-2318/9/56
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Life span assays and mortality rate analysis for germ line-ablated Drosophila Figure 2
Life span assays and mortality rate analysis for germ line-ablated Drosophila. A) Males lacking the germ line. The 
assay consisted of 125 flies for the experimental group and 122 flies for the control group. B) Mortality rate (Gompertz-Make-
ham model) of the germ line-ablated and control male groups. C) Redrawn survival curve for males with age-independent mor-
tality removed. D) Females lacking the germ line. The assay consisted of 118 flies for the experimental group, and 124 flies for 
the control group. E) Mortality rate (Gompertz-Makeham model) of the germ line-ablated and control female groups. F) 
Redrawn survival curve for females with age-independent mortality removed. G) Males lacking the germ line, repeat assay. The 
assay consisted of 238 flies for the experimental group and 139 flies for the control group. H) Mortality rate (Gompertz-Make-
ham model) of the germ line-ablated and control male groups. I) Redrawn survival curve for males with age-independent mor-
tality removed. J) Females lacking the germ line, repeat assay. The assay consisted of 233 flies for the experimental group and 
175 flies for the control group. K) Mortality rate (Gompertz-Makeham model) of the germ line-ablated and control female 
groups. L) Redrawn survival curve with age-independent mortality removed.
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during development was lethal, and over-expression of fru
MA in adults greatly reduced both male and female mean
life span, by -61.97% and -64.5%, respectively (Figure 3K,
L; Table 4, Exp1).
Developmental or adult-specific expression of one or two
inserts of an RNAi construct designed to target the male-
specific isoform of FRU [25] did not affect male life span
(Figure 3M), but surprisingly, decreased female lifespan
significantly (Figure 3N; Table 4). Previous studies where
the Act-GS-255B driver and various RNAi constructs were
used to inactive expression of several genes demonstrates
that RNAi per se does not affect life span [38,39].
Finally, EP-sxl, XP-dsx, and XP-tra2 gene-over-expression
lines were also tested, but did not give a consistent or sig-
nificant change in life span (< 3% change), when
expressed during development or in adults (Table 4,
Exp3).
Discussion
In these experiments, germ line ablation using the
tudor[1] mutation was examined in a long-lived genetic
background, and was found to cause increased mean and
median life span in males (+19% and +12%, respec-
tively), whereas female life span was not affected. In a pre-
vious report, germ line ablation using the tudor[1]
mutation increased the median life span of male flies by
+8.6% [18]. However, germ line ablation was considered
not to have increased life span in that report. Presumably,
this was due to a decrease in female life span, and the fact
that germ line ablation with a germ cell-less mutant failed
to extend life span in either males or females. However,
germ cell-less was reported to have only ~75% penetrance
in that study, which conceivably could have masked any
life span extension. Here the tudor mutation was found to
show a greater increase in life span, and overall longer life
spans were observed for both control and experimental
groups. This is likely due to differences in the genetic
background employed: here the relatively long-lived Ore-
gon-R strain was used for crosses to tudor[1], and the con-
trol males and control females had median life spans of
82 days and 80 days, respectively (Table 2); whereas in the
previous study the relatively shorter-lived Dahomey strain
was utilized for crosses, and produced male control
median life span of 60 days, and female control median
life span of 71 days. In a previous study of D. subobscura,
"ovariless" females lived significantly longer than virgin
female controls or mated female controls [40], and the
difference between this and the present results may be due
to the difference in genetic background, or the difference
in the way or extent of germ line removal caused by spe-
cific mutations. In another recent report, elimination of
GCs was found to extend median life span by +14% to
+78% in males, and by +23% to +100% in females [16].
In those experiments germ line ablation was produced by
mis-expression of the bag of marbles (bam) gene in adult
flies, which caused full sterility by day 7 post-eclosion in
females, and GC depopulation in the 3rd instar larval (L3)
stage or later in males. The presence of a complete germ
line in the earlier stages of development followed by GC
loss at a later stage could affect life span in a different way,
compared with the lack of a germ line from the beginning
of embryogenesis, such as is produced by the tudor muta-
tion. For example, the tudor mutation also partially inhib-
its formation of the somatic gonad, while ablation of GCs
using bam mis-expression at later developmental stages
allows for complete differentiation of the somatic gonad.
Consistent with this idea, in C. elegans, extension of life
span by ablation of the germ line requires the presence of
the somatic gonad [41].
The  Winmodest  program was used to fit the tudor[1]
mutant data to a Gompertz-Makeham model, which
allowed us to separate early mortality from the age-
dependent and age-independent mortality. The analysis
indicated that germ line ablation in male Drosophila
extended life span by decreasing the age-independent
mortality. That implies that germ line ablation provides a
benefit for survival in male flies, and this beneficial effect
is constant over the adult life span. This might occur
through altered IIS as reported for C. elegans hermaphro-
dites [41].
The other manipulations of the sexual differentiation
pathway tested produced either neutral or negative effects
on adult fly life span. For example, conditional over-
expression of tra during development significantly inhib-
ited sexual differentiation in males, yet produced no sig-
nificant change in adult life span. Expression of tra  in
males has previously been found to feminize locomotor
activity patterns [42]. These data demonstrate that it is
possible to alter sexual differentiation and perhaps even
behavior, at least in males, without necessarily having
effects on adult life span.
Over-expression of dsxF during development was lethal to
males and produced a limited number of females, while
over-expression of dsxF  in adults greatly reduced both
male and female life span. Over-expression of dsxM dur-
ing development was toxic to males and females, whereas
over-expression of dsxM in adults produced only a small,
if any, reduction in male and female life span. This indi-
cates that in adults, where sexual differentiation is already
complete, changes in expression of specific sex-determina-
tion pathway genes are still able to have significant effects
on life span.
Interestingly, over-expression of fru  male isoform A
(fruMA) during development was lethal, and over-expres-BMC Geriatrics 2009, 9:56 http://www.biomedcentral.com/1471-2318/9/56
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Table 4: Life span data with means, standard deviations, medians, percent change in mean and median, and log rank p value.
Cross
MxF
RU486 Genotype Sex N Meana  Median %Change in 
Mean
%Change in 
Median
Log 
Rank
p Value 
Exp 1
7-1 - w/Y; 255B/+; + M 122 68.85 ± 14.18 71 --------- --------- ---------
7-1 A w/Y; 255B/+; + M 112 70.64 ± 13.48 73 2.6 2.82 0.646
7-1 L w/Y; 255B/+; + M 145 69.63 ± 12.16 73 1.14 2.82 0.265
7-1 - w/+; 255B/+; + F 121 87.78 ± 8.83 89 --------- --------- ---------
7-1 A w/+; 255B/+; + F 117 88.56 ± 6.85 89 0.89 0 0.615
7-1 L w/+; 255B/+; + F 120 85.96 ± 11.95 89 -2.07 0 0.192
10-1 - w/Y; 255B/tra; + M 122 68.60 ± 15.83 71 --------- --------- ---------
10-1 A w/Y; 255B/tra; + M 118 73.10 ± 13.38 73 6.56 2.82 0.024
10-1 L w/Y; 255B/tra; + M 123 67.54 ± 14.05 69 -1.54 -2.82 0.406
10-1 - w; 255B/tra; + F 122 68.75 ± 18.34 75 --------- --------- ---------
10-1 A w; 255B/tra; + F 122 66.51 ± 15.22 71 -3.27 -5.33 4.91E-05
10-1 L w; 255B/tra; + F 127 73.03 ± 13.07 77 6.22 2.67 0.15
1-5 - w tra2IR/Y;255B/+;tra2IR/+ M 119 74.82 ± 13.69 77 --------- --------- ---------
1-5 A w tra2IR/Y;255B/+;tra2IR/+ M 120 75.33 ± 12.55 75 0.69 -2.6 0.905
1-5 L w tra2IR/Y;255B/+;tra2IR/+ M 122 76.28 ± 13.32 81 1.96 5.19 0.628
1-5 - w tra2IR/w;255B/+;tra2IR/+ F 119 80.43 ± 22.10 91 --------- --------- ---------
1-5 A w tra2IR/w;255B/+;tra2IR/+ F 128 74.20 ± 19.64 80 -7.74 -12.09 4.02E-07
1-5 L w tra2IR/w;255B/+;tra2IR/+ F 127 82.20 ± 20.76 89 2.21 -2.2 0.218
4-1 - w/Y; 255B/dsxM; + M 120 72.39 ± 12.77 73 --------- --------- ---------
4-1 A w/Y; 255B/dsxM; + M 118 66.14 ± 13.80 69 -8.64 -5.48 2.07E-04
4-1 L w/Y; 255B/dsxM; + M 1 67.00 ± NA 67 -7.45 -8.22 0.343
4-1 - w;255B/dsxM; + F 118 77.20 ± 10.40 77 --------- --------- ---------
4-1 A w;255B/dsxM; + F 121 71.91 ± 6.83 71 -6.86 -7.79 6.60E-08
4-1 L w; 255B/dsxM; + F 10 69.60 ± 18.21 70 -9.85 -9.09 0.765
9-1 - w/Y; 255B/+; dsxF/+ M 115 72.23 ± 10.20 75 --------- --------- ---------
9-1 A w/Y; 255B/+; dsxF/+ M 108 29.78 ± 7.60 29 -58.77 -61.33 0
9-1 L w/Y; 255B/+; dsxF/+ M 0 --------- --------- --------- --------- ---------
9-1 - w; 255B/+; dsxF/+ F 117 77.05 ± 19.31 83 --------- --------- ---------
9-1 A w; 255B/+; dsxF/+ F 99 44.06 ± 13.39 45 -42.82 -45.78 0
9-1 L w; 255B/+; dsxF/+ F 23 71.57 ± 21.55 73 -7.12 -12.05 0.191
2-1 - w/Y; 255B/fruMA; + M 118 69.27 ± 12.50 71 --------- --------- ---------
2-1 A w/Y; 255B/fruMA; + M 126 27.83 ± 4.03 27 -59.83 -61.97 0
2-1 L w/Y; 255B/fruMA; + M 0 --------- --------- --------- --------- ---------
2-1 - w/y w; 255B/fruMA; + F 113 90.34 ± 10.49 93 --------- --------- ---------
2-1 A w/y w; 255B/fruMA; + F 123 32.83 ± 7.76 33 -63.66 -64.52 0
2-1 L w/y w; 255B/fruMA; + F 0 --------- --------- --------- --------- ---------
3-1 - w/Y; 255B/fruIR; fruIR/+ M 114 68.63 ± 12.39 71 --------- --------- ---------
3-1 A w/Y; 255B/fruIR; fruIR/+ M 121 68.02 ± 12.20 69 -0.88 -2.82 0.77
3-1 L w/Y; 255B/fruIR; fruIR/+ M 124 66.23 ± 13.69 67 -3.49 -5.63 0.475
3-1 - w; 255B/fruIR; fruIR/+ F 116 76.37 ± 16.00 79 --------- --------- ---------
3-1 A w; 255B/fruIR; fruIR/+ F 120 72.94 ± 11.19 75 -4.49 -5.06 3.26E-07
3-1 L w; 255B/fruIR; fruIR/+ F 124 63.72 ± 21.87 65 -16.57 -17.72 0.002
6-1 - w/Y; 255B/+; + M 116 77.52 ± 13.06 78 --------- --------- ---------
6-1 A w/Y; 255B/+; + M 118 77.46 ± 15.82 79 -0.08 1.28 0.125
6-1 L w/Y; 255B/+; + M 115 76.37 ± 14.50 79 -1.47 1.28 0.361
6-1 - w/w1118; 255B/+; + F 124 78.97 ± 13.48 79 --------- --------- ---------
6-1 A w/w1118; 255B/+; + F 121 76.71 ± 13.57 81 -2.86 2.53 0.008
6-1 L w/w1118; 255B/+; + F 123 81.28 ± 14.17 83 2.93 5.06 0.118
Exp 2
3-1 - w/Y; 255B/fruIR; fruIR/+ M 88 48.77 ± 26.56 58 --------- --------- ---------
3-1 A w/Y; 255B/fruIR; fruIR/+ M 109 61.43 ± 16.27 64 25.95 10.34 0.024
3-1 L w/Y; 255B/fruIR; fruIR/+ M 120 53.65 ± 19.56 56 10 -3.45 0.895
3-1 - w; 255B/fruIR; fruIR/+ F 76 68.45 ± 17.05 73 --------- --------- ---------
3-1 A w; 255B/fruIR; fruIR/+ F 95 58.04 ± 14.35 62 -15.2 -15.07 1.55E-15
3-1 L w; 255B/fruIR; fruIR/+ F 129 53.77 ± 18.60 60 -21.45 -17.81 1.14E-13BMC Geriatrics 2009, 9:56 http://www.biomedcentral.com/1471-2318/9/56
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3-1 - w/Y; 255B/CyO; fruIR/+ M 55 42.18 ± 18.86 46 --------- --------- ---------
3-1 A w/Y; 255B/CyO; fruIR/+ M 66 41.52 ± 12.24 44 -1.58 -4.35 0.066
3-1 L w/Y; 255B/CyO; fruIR/+ M 78 42.38 ± 15.69 44 0.48 -4.35 0.536
3-1 - w;255B/CyO; fruIR/+ F 79 73.75 ± 13.13 76 --------- --------- ---------
3-1 A w; 255B/CyO; fruIR/+ F 86 57.88 ± 14.28 62 -21.51 -18.42 0
3-1 L w; 255B/CyO; fruIR/+ F 101 59.07 ± 13.13 62 -19.9 -18.42 0
6-1 - w/Y; 255B/+; +/+ M 121 62.33 ± 18.12 68 --------- --------- ---------
6-1 A w/Y; 255B/+; +/+ M 117 57.09 ± 22.64 66 -8.4 -2.94 0.165
6-1 L w/Y; 255B/+; +/+ M 119 62.57 ± 16.22 68 0.39 0 0.478
6-1 - w/w1118; 255B/+; +/+ F 123 75.95 ± 9.37 78 --------- --------- ---------
6-1 A w/w1118; 255B/+; +/+ F 122 71.05 ± 13.36 74 -6.45 -5.13 7.97E-06
6-1 L w/w1118; 255B/+; +/+ F 124 69.02 ± 12.88 74 -9.13 -5.13 7.69E-07
Exp 3
7-1 - w/Y; 255B/+; + M 124 72.03 ± 18.30 75 --------- --------- ---------
7-1 A w/Y; 255B/+; + M 123 74.18 ± 20.23 80 2.98 6.67 0.151
7-1 L w/Y; 255B/+; + M 123 71.69 ± 23.51 80 -0.47 6.67 0.171
7-1 - w/+; 255B/+; + F 124 85.39 ± 25.75 92 --------- --------- ---------
7-1 A w/+; 255B/+; + F 118 83.03 ± 25.60 90 -2.76 -2.17 0.043
7-1 L w/+; 255B/+; + F 119 91.78 ± 19.02 96 7.49 4.35 0.213
1-11 R1 - y w sxl/Y; 255B/+; + M 25 85.12 ± 14.30 88 --------- --------- ---------
1-11 R1 A y w sxl/Y; 255B/+; + M 45 85.51 ± 19.71 94 0.46 6.82 0.314
1-11 R1 L y w sxl/Y; 255B/+; + M 76 85.13 ± 13.94 84 0.01 -4.55 0.635
1-11 R1 - y w sxl/w; 255B/+; + F 49 70.45 ± 31.82 82 --------- --------- ---------
1-11 R1 A y w sxl/w; 255B/+; + F 72 57.39 ± 35.23 76 -18.54 -7.32 0.011
1-11 R1 L y w sxl/w; 255B/+; + F 122 83.31 ± 23.54 86 18.26 4.88 0.005
1-11 R2 - y w sxl/Y; 255B/+; + M 67 91.22 ± 21.02 98 --------- --------- ---------
1-11 R2 A y w sxl/Y; 255B/+; + M 75 75.55 ± 22.66 80 -17.19 -18.37 2.30E-09
1-11 R2 L y w sxl/Y; 255B/+; + M 96 86.31 ± 27.48 98 -5.38 0 0.965
1-11 R2 - y w sxl/w; 255B/+; + F 69 89.45 ± 25.26 92 --------- --------- ---------
1-11 R2 A y w sxl/w; 255B/+; + F 74 87.32 ± 18.37 88 -2.38 -4.35 0.064
1-11 R2 L y w sxl/w; 255B/+; + F 121 92.58 ± 17.93 96 3.5 4.35 0.593
11-7 - y w sxl/Y; +; + M 119 92.76 ± 15.18 98 --------- --------- ---------
11-7 - y w sxl/+; +; + F 120 94.48 ± 18.26 98 --------- --------- ---------
10-1 - w/Y; 255B/tra; + M 124 81.47 ± 14.12 82 --------- --------- ---------
10-1 A w/Y; 255B/tra; + M 122 74.48 ± 13.90 76 -8.58 -7.32 2.26E-04
10-1 L w/Y; 255B/tra; + M 124 79.71 ± 16.97 84 -2.16 2.44 0.293
10-1 - w; 255B/tra; + F 127 93.40 ± 15.91 96 --------- --------- ---------
10-1 A w; 255B/tra; + F 123 91.38 ± 18.93 98 -2.16 2.08 0.81
10-1 L w; 255B/tra; + F 126 90.24 ± 22.04 96 -3.39 0 0.732
15-1 - w/Y; 255B/tra2; + M 125 73.44 ± 16.92 76 --------- --------- ---------
15-1 A w/Y; 255B/tra2; + M 124 75.61 ± 15.06 76 2.96 0 0.469
15-1 L w/Y; 255B/tra2; + M 125 74.64 ± 21.79 78 1.63 2.63 0.039
15-1 - w; 255B/tra2; + F 124 78.58 ± 25.27 85 --------- --------- ---------
15-1 A w;255B/tra2; + F 125 77.47 ± 27.00 86 -1.41 1.18 0.789
15-1 L w;255B/tra2; + F 125 79.81 ± 17.45 82 1.56 -3.53 0.144
9-1 - w/Y; 255B/+; dsxF/+ M 74 83.35 ± 22.08 88 --------- --------- ---------
9-1 A w/Y; 255B/+; dsxF/+ M 100 34.20 ± 9.96 32 -58.97 -63.64 0
9-1 L w/Y; 255B/+; dsxF/+ M 0 --------- --------- --------- --------- ---------
9-1 - w; 255B/+; dsxF/+ F 73 87.53 ± 19.27 90 --------- --------- ---------
9-1 A w; 255B/+; dsxF/+ F 98 52.00 ± 13.51 52 -40.59 -42.22 0
9-1 L w; 255B/+; dsxF/+ F 24 67.33 ± 26.60 78 -23.08 -13.33 1.87E-04
14-1 - w/Y; 255B/+;dsx/+ M 124 68.73 ± 21.07 72 --------- --------- ---------
14-1 A w/Y; 255B/+;dsx/+ M 124 70.53 ± 17.57 72 2.63 0 0.88
14-1 L w/Y; 255B/+;dsx/+ M 5 46.00 ± 35.30 50 -33.07 -30.56 0.27
14-1 - w; 255B/+;dsx/+ F 123 65.37 ± 28.78 76 --------- --------- ---------
14-1 A w; 255B/+;dsx/+ F 123 65.56 ± 30.01 76 0.3 0 0.763
14-1 L w; 255B/+;dsx/+ F 123 73.06 ± 17.51 74 11.77 -2.63 0.735
a Mean life span, days +/- SD.
Table 4: Life span data with means, standard deviations, medians, percent change in mean and median, and log rank p value. (Continued)BMC Geriatrics 2009, 9:56 http://www.biomedcentral.com/1471-2318/9/56
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Effect of sex differentiation pathway gene mis-expression on survival of male and female adult flies Figure 3
Effect of sex differentiation pathway gene mis-expression on survival of male and female adult flies. Sexual differ-
entiation pathway genes or RNAi constructs were over-expressed either during larval development ("L"; gray triangles) or in 
adults ("A"; solid squares). Open circles represent the no-drug control ("-"). Survival curves are plotted as a function of adult 
age in days. Median life span and p value for log rank test are indicated in parentheses for each cohort. (A, B) Control flies 
(progeny of driver crossed to Or-R wild type). (C, D) tra. (E, F) tra2-IR. (G, H) dsxM. (I, J) dsxF. (K, L) fruMA. (M, N) fru-IR.
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sion of fruMA in adults greatly reduced both male and
female mean life span. However, expression of an RNAi
construct specific for fruMA  during development or in
adults significantly decreased female life span, but did not
give a consistent change in male life span. The reason for
this effect of fruMA-RNAi in females is not yet clear. In
females, fru P1 transcripts are produced, but not trans-
lated [24]. Possibly the fruMA-RNAi could still function
through fru P1 transcripts to affect female life span, or
could function through targets other than fru.
Taken together with life span results of other assayed
genes, our data show little correspondence between the
sex-specific mode of action of sexual differentiation genes
in development and sex-specific effects of their over-
expression or knockdown on adult lifespan. For example,
adult-specific over-expression of fruMA  and dsxF short-
ened life span to a similar extent in males and females.
This may be because the sex-specificity of these factors is
created during development by means of sex-specific
expression, and in our experiments we are forcing expres-
sion in each sex, thereby eliminating sex-specificity of
action. One possible exception is the developmental
lethality caused by over-expression of dsxF during larval
development, which was complete in males, where it is
not normally expressed, and only partial in females,
where it is normally present.
Sexual differentiation genes play important roles in germ
cell development [20-22]. Therefore, one way that sexual
differentiation genes might regulate life span is by modu-
lating germ cell development. Sexual differentiation genes
also regulate behavior; for example, fru is essential to gen-
erate several male-specific behaviors, including male
courtship behavior [43]. Although the role of sexual dif-
ferentiation genes on behavior has not been examined
specifically in the adult stage, one way sexual differentia-
tion genes might conceivably affect life span is by altering
costly or beneficial behavior patterns in adults. Another
promising direction for future experiments will be to look
at the interactions between sexual differentiation genes
and the pathways and interventions that are known to reg-
ulate life span in a sex-specific manner, such as the insu-
lin/IGF1-like signaling (IIS) pathway and dietary
restriction (DR) [8,10,11].
Conclusion
The data demonstrate that manipulation of sexual differ-
entiation gene expression specifically in the adult, after
morphological sexual differentiation is complete, is able
to affect life span. In addition, by manipulating gene
expression during development, it was possible to signifi-
cantly alter morphological sexual differentiation without
a significant effect on adult life span. The data demon-
strate that manipulation of sexual differentiation pathway
genes either during development or in adults can affect
adult life span, sometimes with sex-specific effects, and
suggest it should be possible in the future to investigate
how the sexual differentiation pathway interacts with spe-
cific life span regulatory genes to produce sex-specific dif-
ferences in longevity.
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Effect of tra over-expression during development on sexual  differentiation of adults Figure 4
Effect of tra over-expression during development on 
sexual differentiation of adults. UAS-tra males were 
crossed to GS255B virgins, cultured on food with drug 
(+RU486) to drive the over-expression of tra during devel-
opment, or cultured on food with ethanol as the control, as 
indicated. Pictures were taken at the magnification of 100X. 
(A, B) Female genitalia. (C, D) Male genitalia. (E, F) Male sex 
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